A multicentre randomised double blind placebo controlled study comparing two regimens of combination induction therapy in early disease-modifying anti-rheumatic drug naïve rheumatoid arthritis

http://isrctn.org/> ◽

10.1186/isrctn48638981 ◽

2013 ◽

Author(s):

Paul Emery

Keyword(s):

Rheumatoid Arthritis ◽

Induction Therapy ◽

Controlled Study ◽

Early Disease ◽

Double Blind ◽

Double Blind Placebo ◽

Drug Naïve ◽

Disease Modifying ◽

Download Full-text

SAT0145 Efficacy and Safety of Sirukumab in Patients with Active Rheumatoid Arthritis despite Disease-Modifying Anti-Rheumatic Drug Treatment: Results of A Randomized, Double-Blind, Placebo-Controlled Study: Table 1.

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2016-eular.3741 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 717.1-717

Author(s):

T. Takeuchi ◽

C. Thorne ◽

G. Karpouzas ◽

S. Sheng ◽

W. Xu ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Drug Treatment ◽

Active Rheumatoid Arthritis ◽

Controlled Study ◽

Efficacy And Safety ◽

Treatment Results ◽

Double Blind ◽

Double Blind Placebo ◽

Disease Modifying ◽

Download Full-text

Results of A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of The Efficacy And Safety of Sirukumab, An Anti-IL-6 Cytokine Monoclonal Antibody, In Patients with Active Rheumatoid Arthritis Despite Disease-Modifying Anti-Rheumatic Drug Treatment (Sirround-D)

Value in Health ◽

10.1016/j.jval.2016.09.1074 ◽

2016 ◽

Vol 19 (7) ◽

pp. A531 ◽

Author(s):

T Takeuchi ◽

C Thorne ◽

G Karpouzas ◽

S Sheng ◽

W Xu ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

Active Rheumatoid Arthritis ◽

Controlled Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Disease Modifying ◽

Download Full-text

A controlled randomised double-blind multicentre study comparing two therapy strategies in disease modifying anti-rheumatic drug-naive early rheumatoid arthritis patients over 48 weeks: induction therapy with adalimumab and methotrexate over 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate monotherapy

http://isrctn.org/> ◽

10.1186/isrctn36745608 ◽

2013 ◽

Author(s):

Gerd-Rüdiger Burmester

Keyword(s):

Rheumatoid Arthritis ◽

Multicentre Study ◽

Early Rheumatoid Arthritis ◽

Induction Therapy ◽

Double Blind ◽

Drug Naïve ◽

Disease Modifying ◽

Therapy Strategies ◽

Download Full-text

Double blind, placebo controlled study of metronidazole as a disease modifying agent in the treatment of rheumatoid arthritis.

Annals of the Rheumatic Diseases ◽

10.1136/ard.51.6.758 ◽

1992 ◽

Vol 51 (6) ◽

pp. 758-760 ◽

Author(s):

D A Marshall ◽

J A Hunter ◽

H A Capell

Keyword(s):

Rheumatoid Arthritis ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Modifying Agent ◽

Disease Modifying

Download Full-text

Metformin Addition Attenuates Olanzapine-Induced Weight Gain in Drug-Naive First-Episode Schizophrenia Patients: A Double-Blind, Placebo-Controlled Study

American Journal of Psychiatry ◽

10.1176/appi.ajp.2007.07010079 ◽

2008 ◽

Vol 165 (3) ◽

pp. 352-358 ◽

Author(s):

Ren-Rong Wu ◽

Jing-Ping Zhao ◽

Xiao-Feng Guo ◽

Yi-Qun He ◽

Mao-Sheng Fang ◽

...

Keyword(s):

Weight Gain ◽

Controlled Study ◽

First Episode ◽

Double Blind ◽

Double Blind Placebo ◽

Drug Naïve ◽

First Episode Schizophrenia

Download Full-text

ADDING LOW-DOSE CYCLOSPORIN A TO PARENTERAL GOLD THERAPY IN RHEUMATOID ARTHRITIS: A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY

Rheumatology ◽

10.1093/rheumatology/35.11.1142 ◽

1995 ◽

Vol 35 (11) ◽

pp. 1142-1149 ◽

Author(s):

G. BENDEX ◽

A. BJELLE

Keyword(s):

Rheumatoid Arthritis ◽

Cyclosporin A ◽

Low Dose ◽

Controlled Study ◽

Double Blind ◽

Gold Therapy ◽

Double Blind Placebo

Download Full-text

AB0471 Efficacy and Tolerability of A Homeopathic Medication Incena in Patients with Rheumatoid Arthritis (Randomized, Double-Blind, Placebo-Controlled Study)

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2014-eular.2889 ◽

2014 ◽

Vol 73 (Suppl 2) ◽

pp. 963.3-964

Author(s):

O. Iaremenko ◽

G. Mykytenko ◽

K. Iaremenko ◽

I. Matiyaschuk ◽

O. Ivashkivsky

Keyword(s):

Rheumatoid Arthritis ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Ofatumumab, a human anti-CD20 monoclonal antibody, for treatment of rheumatoid arthritis with an inadequate response to one or more disease-modifying antirheumatic drugs: Results of a randomized, double-blind, placebo-controlled, phase I/II study

Arthritis & Rheumatism ◽

10.1002/art.27524 ◽

2010 ◽

Vol 62 (8) ◽

pp. 2227-2238 ◽

Author(s):

Mikkel Østergaard ◽

Bo Baslund ◽

William Rigby ◽

Bernadette Rojkovich ◽

Christian Jorgensen ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

Phase I ◽

Inadequate Response ◽

Disease Modifying Antirheumatic Drugs ◽

Antirheumatic Drugs ◽

Double Blind ◽

Double Blind Placebo ◽

Disease Modifying ◽

Download Full-text

Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2012-201365 ◽

2012 ◽

Vol 72 (6) ◽

pp. 851-857 ◽

Author(s):

Marjatta Leirisalo-Repo ◽

Hannu Kautiainen ◽

Leena Laasonen ◽

Markku Korpela ◽

Markku J Kauppi ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Combination Therapy ◽

Early Rheumatoid Arthritis ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

IX 207-887 in Rheumatoid Arthritis. A double-blind placebo-controlled study

Arthritis & Rheumatism ◽

10.1002/art.1780350904 ◽

1992 ◽

Vol 35 (9) ◽

pp. 999-1006 ◽

Author(s):

Maxime Dougados ◽

Bernard Combe ◽

Thomas Beveridge ◽

Isabelle Bourdeix ◽

Anne Lallemand ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text